London, February 2025: uFraction8 Limited (“uFraction8”, “the Company”), a leading microfluidics-based bio-separation technology provider, has closed a £3.4m funding round led by the Ventures team at Foresight Group (“Foresight”) with participation from Old College Capital (“OCC”), Scottish Enterprise, Alwyn Capital and existing investor, Thia Ventures. This includes a £1.5m grant that the Company won from the Polish Agency for Enterprise Development (PARP).

uFraction8 was established in 2017 by Dr. Monika Tomecka (CEO) and Dr. Brian Miller (CTO), based in Scotland and Poland. The technology is based on breakthrough research published in the prestigious Nature journal. 

uFraction8 is commercialising a pioneering microfluidics-based technology that enables continuous bioprocessing of mammalian cell lines, stem cells and microalgae at scale. The technology is addressing customer problems of limited production volumes in bioprocessing, with significant down time between batches, often accompanied by lower quality output/damaged cells, high operating costs and high carbon footprint. The Company provides a reusable patent-protected technology that can scale production volumes by up to 20x to 20,000L while achieving >99% yield.

uFraction8’s microfiltration technology is designed to optimise cell and biomass production, offering a sustainable, energy-efficient alternative to traditional methods. By enhancing the scalability and affordability of bioprocessing, the company is uniquely positioned to address critical challenges in the bioeconomy.
uFraction8 has applications across several markets but has identified three beachhead markets – microalgae, biopharma and alternative protein. The market sizes of microalgae and bio-separation within biopharma are expected to be $3bn and $30bn per annum by 2030 respectively.

This funding will enable further technological development, commercialisation of the technology in Europe and North America and buildout of the team’s sales and manufacturing capabilities. 

Foresight's Ventures team makes equity investments into fast-growing companies that are building some of the most exciting deep tech, hard tech and enterprise software. Foresight works with the founders and management teams to build resilient and prosperous companies to deliver strong economic returns and to have a positive impact on the societies in which they operate. To date, Foresight’s Ventures strategy has invested £80 million and supported 39 deep tech investments.

This investment was also supported by Foresight’s Scottish Growth Fund, which partners with entrepreneurs and management teams to achieve their business ambitions. To date, Foresight has invested over £54 million into growing companies located across Scotland.

Monika Tomecka, CEO and Co-founder at uFraction8 said: “We are thrilled to have secured this investment, which will propel us to the next stage of growth. The support from Foresight Group, Old College Capital, Scottish Enterprise and Alwyn Capital is a testament to the impact and potential of our technology. This funding will enable us to bring our solutions to market more rapidly, particularly within the microalgae and biopharma sectors, while continuing to innovate in the alternative protein sector.”

Rubina Singh, Senior Investment Manager at Foresight added: “At Foresight, we’re committed to supporting pioneering technologies for a sustainable future. We are delighted to be backing Monika and the uFraction8 team in bringing this breakthrough technology to market. uFraction8’s advancements in continuous bioprocessing present transformative opportunities across multiple industries and we are excited to see the impact it can make.”

ENDS

Notes to Editors

For more information contact:
Chris Barry at Influential on 07733 103693 / foresight@thisisinfluential.com
Foresight Group on +44 (0)20 3667 8100 / marketing@foresightgroup.eu

About Foresight Group (“Foresight”) 
Founded in 1984, Foresight is a leading investment manager in real assets and capital for growth, operating across UK, Europe, and Australia.

With decades of experience, Foresight offers investors access to attractive investment opportunities at the forefront of change.  Foresight actively builds and grows investment solutions to support the energy transition, decarbonise industry, enhance nature recovery and realise the economic potential of ambitious companies.

A constituent of the FTSE 250 index, Foresight’s diversified investment strategies combine financial and operational skillsets to maximise asset value and provide attractive returns to its investors. Its wide range of private and public funds is complemented with a variety of investment solutions designed for the retail market.

Foresight is united by a shared commitment to build a sustainable future and grow thriving companies and economies. 
Visit https://foresight.group for more information.
Follow us on LinkedIn for key updates.

About Foresight’s Ventures Strategy
Foresight's Ventures team makes equity investments into fast-growing companies that are building some of the most exciting deep tech, hard tech and enterprise software. It is part of Foresight Group’s award-winning Private Equity division, which specialises in growth & buyout, venture capital and private credit. Its investment team is based across the UK and Ireland, with venture partners based in the US, Israel and UAE. 
Foresight Group, with over £12 billion AUM, invests to support the energy transition, decarbonise industry, enhance nature recovery and realise the economic potential and positive impact of ambitious companies.